Objective: To investigate the effect of compound Danshen on implanted bone binding and expression of transforming growth factor-β1(TGF-β1) in diabetic rats. Methods: 45 rats were randomly divided into control group, model group(established diabetes model), and compound danshen group(established diabetic model plus compound danshen tablet). The level of blood glucose and insulin before and after treatment were determined. The number of trabecular bone, trabecular thickness, trabecular space and bone volume fraction around the implant were measured by CT specimens, the expression of TGF-β1 protein around the implant was measured by immunohistochemistry, the level of TGF-β1 mRNA around the implant was measured by RT-PCR. Results: Before treatment, the blood sugar level of the model group and the compound Danshen group were significantly(P<0.05) higher than the control group,, while the insulin level was significantly(P<0.05) reduced. After treatment, compared with the model group, the blood glucose and insulin of the compound Danshen group significantly(P<0.05) decreased, and the number of trabecular bone, thickness of trabecular bone, bone volume fraction, maximum extraction force of implant and level of TGF-β1 around implant in model group and compound danshen group were significantly (P<0.05) reduced, but the trabecular space was increased (P<0.05). Furthermore, the number of trabecular bone, thickness of trabecular bone, bone volume fraction, maximum extraction force of implant, and level of TGF-β1 around implant in compound danshen group were higher than those in the model group (P<0.05), while the trabecular space was lower than that of model group (P<0.05).Conclusion: Compound danshen increases the expression of TGF-β1 around the implant in diabetic rats and promote implant bone cementation. |
[1] LADHA K,SHARMA A,TIWARI B,et al.Bone augmentation as an adjunct to dental implant rehabilitation in patients with diabetes mellitus:a review of literature[J].Natl J Maxillofac Surg,2017,8(2):95-101.
[2] 李晓明,李惠山,崔晓慧,等.种植体周围炎发病率及相关因素的研究[J].大连医科大学学报,2017,39(4):334-338.
[3] TONG S,XU D P,LIU Z M,et al.Synthesis of and in vitro and in vivo evaluation of a novel TGF-β1-SF-CS three-dimensional scaffold for bone tissue engineering[J].Int J Mol Med,2016,38(2):367-380.
[4] 秦凤宜,吴志镛.复方丹参滴丸辅助治疗58例2型糖尿病临床疗效观察[J].现代诊断与治疗,2013,24(20):4587-4588.
[5] YAN X,ZHANG X W,CHI W C,et al.Association between implant apex and sinus floor in posterior maxilla dental implantation:a three-dimensional finite element analysis[J].Exp Ther Med,2015,9(3):868-876.
[6] HANIF A,QURESHI S,SHEIKH Z,et al.Complications in implant dentistry[J].Eur J Dent,2017,11(1):135-140.
[7] NAUJOKAT H,KUNZENDORF B,WILTFANG J.Dental implants and diabetes mellitus-a systematic review[J].Int J Implant Dent,2016,2(1):5.
[8] 刘晶,朱国慧,张恩,等.口腔种植体周围炎与糖尿病[J].中国组织工程研究,2016,20(38):5764-5769.
[9] OATES T W,HUYNH-BA G,VARGAS A,et al.A critical review of diabetes,glycemic control and dental implant therapy[J].Clin Oral Implants Res,2013,24(2):117-127.
[10] OATES T W,JR GALLOWAY P,ALEXANDER P,et al.The effects of elevated hemoglobin A1c in patients with type 2 diabetes mellitus on dental implants:survival and stability at one year[J].J Am Dent Assoc,2014,145(12):1218-1226.
[11] UPTON P D,DAVIES R J,TAJSIC T,et al.Transforming growth factor-β1 represses bone morphogenetic protein-mediated smad signaling in pulmonary artery smooth muscle cells via Smad3[J].Am J Respir Cell Mol Biol,2013,49(6):1135-1145.
[12] DANG P N,DWIVEDI N,PHILLIPS L M,et al.Controlled dual growth factor delivery from microparticles incorporated within human bone marrow-derived mesenchymal stem cell aggregates for enhanced bone tissue engineering via endochondral ossification[J].Stem Cells Transl Med,2016,5(2):206-217.
[13] CHIBA T,ISHISAKI A,KYAKUMOTO S,et al.Transforming growth factor-β1 suppresses bone morphogenetic protein-2-induced mesenchymal-epithelial transition in HSC-4 human oral squamous cell carcinoma cells via Smad1/5/9 pathway suppression[J].Oncol Rep,2017,37(2):713-720.
[14] 林成,刘宝林,刘彦普,等.VEGF和TGF-β1促进非血管化骨移植同期种植骨结合的实验研究[J].实用口腔医学杂志,2011,27(1):12-16.
[15] 邹月.复方丹参滴丸药理作用及代谢研究进展[J].临床合理用药杂志,2018,11(3):162-163.
[16] 许骏尧,张承华,时孝晴,等.复方丹参滴丸联合西药治疗糖尿病周围神经病变的Meta分析[J].中成药,2018,40(4):813-820.
[17] 王薇,王怀清,杨建明,等.复方丹参滴丸对2型糖尿病大鼠代谢、生化指标及缺氧诱导因子-1α/血管内皮生长因子通路的影响[J].中国老年学杂志,2018,38(4):935-937. |